Dr. Kate Hillier‘s practice focuses on the representation of public and private life sciences companies discovering, developing and marketing biopharmaceutical, vaccine, medical device, diagnostic and digital health products.
Kate counsels clients in relation to transactions involving complex intellectual property, business, operational and legal issues, with the aim of maximizing the value of her clients’ products and technology. She works closely with her clients in connection with their overall licensing and partnering strategy, and structuring and negotiating critical transactions. In addition, she counsels clients on matters involving supply, distribution, clinical trials, research collaborations and vendor services.
Prior to qualifying as an attorney, Kate worked as a qualified anesthesiologist in Australia and the UK, completing her residency in anesthesiology and intensive care and working as a consultant anesthesiologist in the UK, where she was a member of the hospital’s ethics committee. She draws heavily on her academic and clinical experience in medicine and anesthesia in developing a deeper understanding of her clients’ technology, and in advising them in the context of complex transactions in the life sciences field.